CMS considers paying all Medicare providers for cancer gene therapies – ModernHealthcare.com
ModernHealthcare.com |
CMS considers paying all Medicare providers for cancer gene therapies
ModernHealthcare.com The CMS is considering reimbursing all Medicare providers for one-time cancer treatments that genetically alter patients' cells to fight the disease. The move could increase revenue by millions at each hospital using the therapy. The FDA cleared two … |
